PROGRAM INTERCHANGE Japan

Similar documents
CDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research

2014 CDISC International Interchange Conference Program

CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013

S t r e n g t h t h r o u g h C o l l a b o r a t i o n

Now We are Getting to the Hard Parts: An Analysis Files Perspective

Beijing esubmission Packages

PDUFA IV Information Technology Plan. Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA

CDISC 2012 Annual Report TEAMWORK.... with collaboration there is strength.

Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare

Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland

Site-Less CRO Model and esource: Framework for Action

New Streams of Risk Management. Tomiko TAWARAGI Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA)

Data Elements: Bridging Clinical & Research Data

Clinical Research Professionals

Introduction to China CDISC Coordinating Committee (C3C) February 2014

MARKET SCOPING MISSION INFORMATION CONSTRUCTION & BUILDING TECHNOLOGIES NOVEMBER 2018, JAPAN

BUSINESS MISSION INFORMATION GREEN ENERGY TECHNOLOGIES 21 JANUARY 25 JANUARY 2019, KOREA

Clinical Data Quality Summit

EU GREEN GATEWAY TO JAPAN

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

BUSINESS MISSION INFORMATION HEALTHCARE & MEDICAL TECHNOLOGIES 11 MARCH 15 MARCH 2019, KOREA

PMDA EPOCH Toward 2020

Paper PO 53. Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study

Office of the Chief Information Officer (HFA 080) Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

CHI 2013 Invitation to Sponsor I page 1

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS

Targeted technology and data management solutions for observational studies

ASQN 2016 IN JEJU EVENT INFORMATION. CONNECTING ASIA, CHANGING TOMORROW and SHARING FUTURE!!

FDA Information Day: who should attend. Detailed Update on the Latest Information for ICSR and IDMP. Individual Case Safety Reports

Role and Vision of PMDA

Potential of the use of electronic patient information for clinical research in the pharmaceutical industry

SOP Title: Reporting Adverse Events and New Safety Information

International trend on medical device regulatory convergence

WYSIWYG CO., LTD. October 2015

13th XBRL International Conference May 16-19, 2006 Madrid, Spain. A Working Reality: Sharing the Same Language

FINAL STATUS DOCUMENT

Registries for Evaluating Patient Outcomes: A User s Guide

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Sustainable Chemistry & Engineering in the 21st Century

HL7 capabilities for working with GS1

OWASP DC AppSec Conference 2009 Volunteer Guide

GCP Inspection by PMDA

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Pharmacovigilance in Middle East Conference

Various Views on Adverse Events: a collection of definitions.

36 th Annual Meeting Preconference Workshop P4 Handout

The Pharmaceutical Risk Assessment Committee (PRAC) of the EMA

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Invitation to Apply for Partnering Forum 2007

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan

September 2-3, 2013 Chengdu, China

ISEC 2017 SPONSORSHIP & EXHIBITION PROSPECTUS. International Solvent Extraction Conference 2017

Asian Open Access Meeting Report

Progress Report in 2016

Registries for Evaluating Patient Outcomes:

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

1st Maghreb Regulatory Conference

Mid-term Targets of the Pharmaceuticals and Medical Devices Agency (PMDA) *(Provisional Translation)

IMDRF FINAL DOCUMENT. Title: Strategic Assessment of Electronic Submission Messaging Formats

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

Creating and Nurturing Startups That Can Contribute to the Development of New Key Industries

7 th European Forum for Qualified Person for Pharmacovigilance (QPPV)

19-24 OCT2017 TECHNOPOLIS CITY OF ATHENS. ehealth: equal access to health & sustainable growth CONFERENCE OCT. 2017

europeana business plan 2012

Delivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK)

Seminars, Events & Training 2018

Pharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea

Reserve your space today!

South Carolina Trade Mission to South Korea and Japan September 5-11, 2018

PMDA Update: Its current situation

Observers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X

S P O N S O R P R O S P E C T U S

RECORD RETENTION: Imaging Data Longevity

SMARTCare Site Job Descriptions Site Physician Lead (Champion)

International Perspectives. Marjorie S. Greenberg, MA National Center for Health Statistics Centers for Disease Control and Prevention

BUILD YOUR OWN CONFERENCE!

Experiences of using routinely collected medical data in a cardiovascular safety trial?

esubmission roadmap v2.0: Industry viewpoint

E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Measuring Impact in Patient-Centered Drug Development Conference

...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS

Applied Bioinformatics 2018 Draft Schedule

Global Innovation from Tokyo

The Global Stage. FOR innovation. impact VOLUNTEER GUIDE NMSDC CONFERENCE + BUSINESS OPPORTUNITY EXCHANGE OCT AUSTIN, TX

DEPARTMENT OF RESEARCH POLICY AND COOPERATION WORLD HEALTH ORGANIZATION

NATIONAL SCIENCE FOUNDATION - INDUSTRY / UNIVERSITY COOPERATIVE RESEARCH CENTERS PROGRAM EVALUATOR MEETING. June 14-15, 2007

KONNECT 1 st PERIODIC REPORT

Newsletter. Letter from the president. Spring Inside this issue: Yi Jin, PhD, DABT AACT President. Dear AACT Members,

Current status on Adverse Event Reporting in Japan

SHARESOURCE Connectivity Platform Get Connected to Patients on Home Peritoneal Dialysis. Making possible personal.

Clinical Data Transparency and e-submissions Mumbai, India. 14th March India SDE

Social Networks for Pharmacovigilance: different approaches for managing signals from ICRS to Twitter

ICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY

NEWS, KNOWLEGDE, EXPERIENCE & INSPIRATION. ectd. a practical perspective

MONDAY, APRIL 21, 2014

Submission of new substance and IMP data in the extended EudraVigilance Medicinal Product Dictionary (XEVMPD)

BUSINESS MISSION INFORMATION HEALTHCARE & MEDICAL TECHNOLOGIES 9 13 APRIL 2018, CHINA

2-5, 2018 EXHIBIT & SPONSORSHIP OPPORTUNITIES

H2020 Programme. Guidelines on Open Access to Scientific Publications and Research Data in Horizon 2020

Transcription:

A collaborative event to share progress, implementation experiences, and strategic ideas on worldwide data interchange standards for medical research. PROGRAM INTERCHANGE Japan 20-23 July 2010 Toshi Center Hotel Tokyo Japan 28 June 2010

Dear All, On behalf of the Japan CDISC Coordinating (J3C), I would like to thank you for your contributions to the 2010 CDISC Japan Interchange on July 20-23 at Toshi Center hotel in Tokyo. At the main conference on Tuesday-Wednesday July 20-21, you can learn the most up to date status of the CDISC standards and initiatives, including: CDSIC SHARE, FDA s data standards implementation plan for regulatory submissions and regional activities from Rebecca Kush, CDISC President & CEO, CDISC experts and chairpersons of the Regional CDISC Coordinating s. CDISC official training courses will take place on Thursday-Friday July 22-23. In addition to SDTM, ADaM and CDASH courses, Protocol Representation course which is a first time in Japan is also available this year. As you may know, CDISC is not just for regulatory submission standards, but it is also effective and useful standards in the clinical trial processes whether US, Europe, Japan or anywhere. We believe this is a crucial opportunity to update your knowledge and skills on the CDISC for the further steps. We are pleased to share the recent topics on CDISC standards with you at the Japan Interchange. With kind regards, Yoshio Tsukada Chairperson of Japan CDISC Coordinating Strength through collaboration.

CDISC INTERCHANGE, JAPAN 2010 CONFERENCE-AT-A-GLANCE TUESDAY 20 JULY 09:00-17:00 Registration 09:30-10:30 Session 1: Welcome & Keynote 10:30-11:00 Coffee 11:00-12:30 Session 2: CDISC Regional Update 12:30-13:30 Lunch 13:30-15:00 Session 3: CDISC Standards Update 15:00-15:30 Coffee 15:30-17:00 Session 4: Integration of Standards and Processes 18:00-20:00 Evening Reception WEDNESDAY 21 JULY 09:00-10:45 Session 5: Safety Data & CDISC 10:45-11:15 Coffee 11:15-12:45 Session 6: CDISC - Current Practice & Future in Japan 12:45-13:45 Lunch 13:45-15:15 Session 7: CDISC More in Japan 15:15-15:45 Coffee 15:45-16:45 Session 8: Vendor Applications & Tools 16:45-17:00 Session 9: Closing Address THURSDAY 22 JULY 09:00-17:00 SDTM v3.1.2 Training: Application and Theory 09:00-17:00 ADaM Training: An Implementation Course 09:00-12:30 CDASH Training: An Introduction 13:30-17:00 Protocol Representation Training: An Introduction FRIDAY 23 JULY 09:00-17:00 SDTM v3.1.2 Training: Application and Theory (Continued)

CDISC INTERCHANGE JAPAN SESSION DETAILS TUESDAY 20 JULY 2010 Interchange Conference, Cosmos Hall, 3rd Floor (Japanese - English simultaneous interpretation is available) 09:00-17:00 Registration 09:30-17:00 Exhibition Open (6th Floor) 09:30-10:30 Session 1: Welcome & Keynote Chair: Yoshio Tsukada, Chair of the Japanese CDISC Coordinating 10:30-11:00 Coffee Welcome to the 2010 CDISC Interchange in Japan Yoshio Tsukada, Chair of the Japanese CDISC Coordinating State of the CDISC Union Rebecca Kush, CDISC President and CEO Keynote Speech Key Factors for Development of Clinical Research in Japan Potential of Introduction of National ID System (To be confirmed) Shinichi Nozaki, Counselor Office of Health and Welfare for Director- General for Policy Planning and Evaluation, MHLW Keynote Speech Recent trends of Clinical Trials and Clinical Researches Interim review of the new 5 yearly clinical trial activation plan Yuta Nakaya, Office of Clinical Trial Promotion, Research and Development Division, Health Policy Bureau, MHLW 11:00-12:30 Session 2: CDISC Regional Update Chair: Hiroshi Azuma, Vice Chair of the Japanese CDISC Coordinating 12:30-13:30 Lunch CDISC Europe Update Pierre-Yves Lastic, Chair of the European CDISC Coordinating CDISC Korea Update Sukil Kim, Chair of the Korean CDISC Coordinating CDISC Japan Update Kiyoteru Takenouchi, Past Chair of the Japanese CDISC Coordinating 13:30-15:00 Session 3: CDISC Standards Update Chair: Kiyoteru Takenouchi, Past Chair of the Japanese CDISC Coordinating 15:00-15:30 Coffee CDISC Standards: Current and Future Rebecca Kush, CDISC President and CEO CDISC SHARE: The CDISC Metadata Repository Gary Walker, Quintiles Integrating Business Processes between Healthcare and Research Landen Bain, CDISC Liaison to Healthcare

15:30-17:00 Session 4: Integration of Standards and Processes Chair: Motohide Nishi, Vice Chair, Japanese CDISC Coordinating Disease-specific Data Standards: Case Studies in TB, Cardiology and Neurology Bron Kisler, CDISC Senior Director of Terminology Define.XML It s Not just for Submissions Any More Joel Hoffman, Phase Forward Introduction about our activities on diffusion and implementation of CDISC standards in Translational Research Informatics Center Kotone Matsuyama, TRI Center 18:00-20:00 CDISC Evening Reception WEDNESDAY 21 JULY 2010 Interchange Conference, Cosmos Hall, 3rd Floor (Japanese - English simultaneous interpretation is available) 09:00-17:00 Exhibition Open (6th Floor) 09:00-10:45 Session 5: Safety Data & CDISC Chair: Yutaka Sugihara, Japanese CDISC Coordinating 10:45-11:15 Coffee Using CDASH data collection forms for automated SAE reporting Andrew Newbigging, Medidata Solutions Worldwide Doing more with SDTM Safety Signal Detection on Clinical Trial Data Robbert P. van Manen, Phase Forward E2B Under the Umbrella of HL7 and BRIDG: Looking to the future of data integrations between Pharmacovigilance (E2B) and Clinical Trial Management Joerge Dillert, Phase Forward Europe MIHARI Project PMDA s Pharmacovigilance project with information out of Japan s HIS Michio Kimura, Hamamatsu University School of Medicine, Ayumi Endo, Pharmaceuticals and Medical Devices Agency 11:15-12:45 Session 6: CDISC Current Practice & Future in Japan Chair: Toshiaki Ogawa, Japanese CDISC Coordinating 12:45-13:45 Lunch Neotor Project: A real academic clinical trial using CDISC ODM-based EDC Takahiro Kiuchi, UMIN Center Remoted-SDV using electronic regional medical network system Akimasa Yamatani, National Hospital Organization Kanazawa Medical Center Industry Effort for Implementation of CDISC in Japan Yoshiko Terui, JPMA

13:45-15:15 Session 7: CDISC More in Japan Chair: Hisao Iizuka, Japanese CDISC Coordinating 15:15-15:45 Coffee Activities on CJUG CDASH Kazuki Furuno, CJUG CDASH Team CJUG Activities on SDTM implementation team Yoshiteru Chiba, CJUG SDTM team, UMIN Center Activities on CJUG ADaM Hiroki Takagi, CJUG ADaM Team, Sanofi-Aventis 15:45-16:45 Session 8: Vendor Applications and Tools Chair: Kenji Nagaya, Japanese CDISC Coordinating Cloud based Clinical Trial Management Systems (CTMS) Chris Merriam-Leith, Transgenic Software Simplifying trial data extraction with CDISC ODM as web service interface Herve Ouambo Fotso, Phase Forward Europe 16:45-17:00 Session 9: Closing Address Hiroshi Azuma, Vice Chair of the Japanese CDISC Coordinating THURSDAY 22 JULY 2010 (CDISC Official Training Courses, 7th floor), 09:00-17:00 Training: SDTM v 3.1.2: Application & Theory (Room #703) Gary Walker, Quintiles The SDTM (Study Data Tabulation Model) v3.1.2 is a specification in the FDA ectd Guidance as the model for submitting clinical and preclinical data to the FDA. This two-day course consists of: A detailed review of SDTM concepts, SDTM domain models, and relationship tables A discussion of common implementation issues, and exercises including CRF-annotations Creation of SDTM datasets that reinforce attendees understanding of the SDTM and the SDTM Implementation Guide 09:00-17:00 Training: ADaM Implementation (Room #707) Florence Somers, Business & Decision Life Sciences This course discusses the purpose of analysis datasets, the basic principles of the ADaM data standard, how ADaM fits in the CDISC framework, and the relationship between ADaM and SDTM. Attendees will learn specifics about the subject-level analysis data model and how to start to apply the ADaM standards right now.

09:00-12:30 Training: CDASH: An Introduction (Room #705) Rebecca Kush, CDISC President & CEO, Bron Kisler, Senior Director Terminology This half-day course will provide attendees with an overview of the CDASH and Terminology projects as well as covering history and philosophy. This course will provide the information needed to facilitate access, implementation and use of these important standards. 13:30-17:00 Training: Protocol Representation: An Introduction (Room #705) Rebecca Kush, CDISC President & CEO, Bron Kisler, Senior Director Terminology This is the first time the Protocol Representation course has been offered in Japan. The objective of the Protocol Representation model is publication of a standard, machine-readable model for protocol representation that will enable interchange of this data among systems and stakeholders. This halfday course will describe the first release of the Protocol Representation Standard, which includes Clinical Trial Registry, Trial Design, and Eligibility Criteria. FRIDAY 23 JULY 2010 (CDISC Official Training Course, 7th floor) 09:00-17:00 Training (Continued): SDTM v3.1.2: Application & Theory (Room #703)

Clinical Data Interchange Standards Consortium 15907 Two Rivers Cove, Austin, Texas 78717 512.341.9885 www.cdisc.org Corporate Benefactors